Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cysteine-type deubiquitinase activity	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P PAN2 USP17L3 USP17L22 USP17L15 USP17L13	1.04e-21	114	131	19	GO:0004843
GeneOntologyMolecularFunction	deubiquitinase activity	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P PAN2 USP17L3 USP17L22 USP17L15 USP17L13	5.55e-21	124	131	19	GO:0101005
GeneOntologyMolecularFunction	ubiquitin-like protein peptidase activity	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P PAN2 USP17L3 USP17L22 USP17L15 USP17L13	3.98e-20	137	131	19	GO:0019783
GeneOntologyMolecularFunction	cysteine-type peptidase activity	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P PAN2 USP17L3 USP17L22 USP17L15 CAPN15 USP17L13	1.31e-18	192	131	20	GO:0008234
GeneOntologyMolecularFunction	peptidase activity	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 PSMB7 USP17L5 USP17L10 USP17L19 USP17L18 RNPEP USP17L17 USP17L6P PAN2 USP17L3 USP17L22 USP17L15 CAPN15 USP17L13	2.80e-10	654	131	22	GO:0008233
GeneOntologyMolecularFunction	C-C chemokine binding	CCRL2 CCR6 ACKR1 CX3CR1	1.70e-05	24	131	4	GO:0019957
GeneOntologyMolecularFunction	G protein-coupled receptor activity	MRGPRF MRGPRE CCRL2 TAAR5 OR8J1 OR5M8 OR6P1 OPRM1 LHCGR OR52I2 OR6A2 OR4C3 CELSR2 CCR6 OR4B1 ACKR1 ADGRF1 CX3CR1	1.91e-05	884	131	18	GO:0004930
GeneOntologyMolecularFunction	chemokine binding	CCRL2 CCR6 ACKR1 CX3CR1	6.25e-05	33	131	4	GO:0019956
GeneOntologyMolecularFunction	protein kinase C binding	PRKD2 UGT1A7 ADCY6 PDLIM5 LDB3	7.30e-05	66	131	5	GO:0005080
GeneOntologyMolecularFunction	RNA transmembrane transporter activity	SIDT1 SIDT2	1.28e-04	3	131	2	GO:0051033
GeneOntologyMolecularFunction	nucleic acid transmembrane transporter activity	SIDT1 SIDT2	1.28e-04	3	131	2	GO:0051032
GeneOntologyMolecularFunction	low-density lipoprotein particle receptor activity	STAB2 LRP2 LRP6	1.45e-04	16	131	3	GO:0005041
GeneOntologyMolecularFunction	transmembrane signaling receptor activity	MRGPRF MRGPRE CCRL2 TAAR5 OR8J1 OR5M8 OR6P1 OPRM1 LHCGR OR52I2 OR6A2 OR4C3 CELSR2 LRP6 CCR6 OR4B1 ACKR1 ADGRF1 LTBP4 NOTCH1 CX3CR1	1.91e-04	1353	131	21	GO:0004888
GeneOntologyMolecularFunction	extracellular matrix structural constituent	FRAS1 MATN2 SLIT2 FBLN1 FBLN2 LTBP4 FBN3	2.45e-04	188	131	7	GO:0005201
GeneOntologyMolecularFunction	ethanolamine kinase activity	ETNK2 ETNK1	2.54e-04	4	131	2	GO:0004305
GeneOntologyMolecularFunction	lipoprotein particle receptor activity	STAB2 LRP2 LRP6	3.37e-04	21	131	3	GO:0030228
GeneOntologyMolecularFunction	calcium ion binding	STAB2 MATN2 SLIT2 FBLN1 FBLN2 SCUBE2 CELSR2 SLIT1 LRP2 LTBP4 FBN3 NOTCH1 NOTCH4 ALPL	4.10e-04	749	131	14	GO:0005509
GeneOntologyMolecularFunction	C-C chemokine receptor activity	CCRL2 CCR6 CX3CR1	4.44e-04	23	131	3	GO:0016493
GeneOntologyMolecularFunction	G protein-coupled chemoattractant receptor activity	CCRL2 CCR6 CX3CR1	6.42e-04	26	131	3	GO:0001637
GeneOntologyMolecularFunction	chemokine receptor activity	CCRL2 CCR6 CX3CR1	6.42e-04	26	131	3	GO:0004950
GeneOntologyMolecularFunction	hyaluronic acid binding	STAB2 USP17L24 USP17L6P	8.90e-04	29	131	3	GO:0005540
GeneOntologyMolecularFunction	RNA polymerase I general transcription initiation factor activity	RRN3 RRN3P1	1.49e-03	9	131	2	GO:0001181
GeneOntologyBiologicalProcess	protein deubiquitination	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	9.96e-20	125	130	18	GO:0016579
GeneOntologyBiologicalProcess	protein modification by small protein removal	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.38e-18	144	130	18	GO:0070646
GeneOntologyBiologicalProcess	protein modification by small protein conjugation or removal	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 TRIM34 USP17L10 USP17L19 USP17L18 RNF123 NEURL3 USP17L17 USP17L6P ANKIB1 USP17L3 USP17L22 UHRF2 USP17L15 USP17L13	7.71e-08	1009	130	23	GO:0070647
GeneOntologyBiologicalProcess	post-translational protein modification	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 TRIM34 USP17L10 USP17L19 USP17L18 RNF123 NEURL3 USP17L17 USP17L6P ANKIB1 USP17L3 USP17L22 UHRF2 USP17L15 USP17L13	2.35e-07	1074	130	23	GO:0043687
GeneOntologyCellularComponent	endoplasmic reticulum membrane	USP17L21 USP17L4 USP17L2 USP17L12 RETREG2 USP17L1 USP17L20 USP17L11 UGT1A7 RDH10 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 CSPG5 USP17L6P USP17L3 USP17L22 USP17L15 NOTCH1 NOTCH4 USP17L13	5.14e-06	1293	131	23	GO:0005789
GeneOntologyCellularComponent	endoplasmic reticulum subcompartment	USP17L21 USP17L4 USP17L2 USP17L12 RETREG2 USP17L1 USP17L20 USP17L11 UGT1A7 RDH10 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 CSPG5 USP17L6P USP17L3 USP17L22 USP17L15 NOTCH1 NOTCH4 USP17L13	5.55e-06	1299	131	23	GO:0098827
GeneOntologyCellularComponent	nuclear outer membrane-endoplasmic reticulum membrane network	USP17L21 USP17L4 USP17L2 USP17L12 RETREG2 USP17L1 USP17L20 USP17L11 UGT1A7 RDH10 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 CSPG5 USP17L6P USP17L3 USP17L22 USP17L15 NOTCH1 NOTCH4 USP17L13	7.86e-06	1327	131	23	GO:0042175
MousePheno	increased trophectoderm apoptosis	USP17L2 USP17L15 USP17L13	1.51e-05	8	92	3	MP:0012119
Domain	HABP4_PAI-RBP1	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	2.17e-26	16	128	13	PF04774
Domain	HABP4_PAIRBP1-bd	USP17L21 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	2.17e-26	16	128	13	IPR006861
Domain	UCH	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 PAN2 USP17L3 USP17L22 USP17L13	4.11e-22	71	128	17	PF00443
Domain	USP_3	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 PAN2 USP17L3 USP17L22 USP17L13	5.35e-22	72	128	17	PS50235
Domain	USP_dom	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 PAN2 USP17L3 USP17L22 USP17L13	5.35e-22	72	128	17	IPR028889
Domain	Peptidase_C19_UCH	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 PAN2 USP17L3 USP17L22 USP17L13	5.35e-22	72	128	17	IPR001394
Domain	USP_2	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	2.10e-20	71	128	16	PS00973
Domain	USP_CS	USP17L21 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	2.97e-19	66	128	15	IPR018200
Domain	USP_1	USP17L21 USP17L4 USP17L2 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L3 USP17L22 USP17L13	7.81e-19	70	128	15	PS00972
Domain	EGF	FRAS1 STAB2 NRG4 MATN2 PGAP6 VWDE SLIT2 FBLN1 FBLN2 FCGBP SCUBE2 CELSR2 CSPG5 SLIT1 LRP2 LRP6 LTBP4 FBN3 NOTCH1 NOTCH4	1.58e-16	235	128	20	SM00181
Domain	EGF-like_dom	FRAS1 STAB2 NRG4 MATN2 PGAP6 VWDE SLIT2 FBLN1 FBLN2 FCGBP SCUBE2 CELSR2 CSPG5 SLIT1 LRP2 LRP6 LTBP4 FBN3 NOTCH1 NOTCH4	4.87e-16	249	128	20	IPR000742
Domain	EGF_3	STAB2 NRG4 MATN2 PGAP6 VWDE SLIT2 FBLN1 FBLN2 SCUBE2 CELSR2 CSPG5 SLIT1 LRP2 LRP6 LTBP4 FBN3 NOTCH1 NOTCH4	3.62e-14	235	128	18	PS50026
Domain	EGF-like_CS	STAB2 NRG4 MATN2 PGAP6 VWDE SLIT2 FBLN1 FBLN2 SCUBE2 CELSR2 CSPG5 SLIT1 LRP2 LRP6 LTBP4 FBN3 NOTCH1 NOTCH4	2.21e-13	261	128	18	IPR013032
Domain	EGF_2	STAB2 NRG4 MATN2 PGAP6 VWDE SLIT2 FBLN1 FBLN2 SCUBE2 CELSR2 CSPG5 SLIT1 LRP2 LRP6 LTBP4 FBN3 NOTCH1 NOTCH4	2.87e-13	265	128	18	PS01186
Domain	EGF_1	STAB2 NRG4 PGAP6 VWDE SLIT2 FBLN1 FBLN2 SCUBE2 CELSR2 CSPG5 SLIT1 LRP2 LRP6 LTBP4 FBN3 NOTCH1 NOTCH4	1.86e-12	255	128	17	PS00022
Domain	EGF_CA	STAB2 MATN2 SLIT2 FBLN1 FBLN2 SCUBE2 CELSR2 SLIT1 LRP2 LTBP4 FBN3 NOTCH1 NOTCH4	2.31e-12	122	128	13	SM00179
Domain	EGF-like_Ca-bd_dom	STAB2 MATN2 SLIT2 FBLN1 FBLN2 SCUBE2 CELSR2 SLIT1 LRP2 LTBP4 FBN3 NOTCH1 NOTCH4	2.85e-12	124	128	13	IPR001881
Domain	EGF-type_Asp/Asn_hydroxyl_site	MATN2 SLIT2 FBLN1 FBLN2 SCUBE2 CELSR2 SLIT1 LRP2 LTBP4 FBN3 NOTCH1 NOTCH4	8.11e-12	106	128	12	IPR000152
Domain	Growth_fac_rcpt_	FRAS1 STAB2 MATN2 FBLN1 FBLN2 SCUBE2 CELSR2 SLIT1 LRP2 LTBP4 FBN3 NOTCH1 NOTCH4	5.38e-11	156	128	13	IPR009030
Domain	EGF	STAB2 NRG4 MATN2 SLIT2 SCUBE2 CELSR2 SLIT1 LRP2 LRP6 FBN3 NOTCH1 NOTCH4	6.39e-11	126	128	12	PF00008
Domain	ASX_HYDROXYL	MATN2 SLIT2 FBLN1 FBLN2 SCUBE2 CELSR2 LRP2 LTBP4 FBN3 NOTCH1 NOTCH4	8.56e-11	100	128	11	PS00010
Domain	EGF_Ca-bd_CS	SLIT2 FBLN1 FBLN2 SCUBE2 SLIT1 LRP2 LTBP4 FBN3 NOTCH1 NOTCH4	1.22e-09	97	128	10	IPR018097
Domain	EGF_CA	SLIT2 FBLN1 FBLN2 SCUBE2 SLIT1 LRP2 LTBP4 FBN3 NOTCH1 NOTCH4	1.49e-09	99	128	10	PS01187
Domain	EGF_CA	MATN2 FBLN1 FBLN2 SCUBE2 LRP2 LTBP4 FBN3 NOTCH1 NOTCH4	7.40e-09	86	128	9	PF07645
Domain	cEGF	MATN2 FBLN1 FBLN2 SCUBE2 LRP2 FBN3	1.89e-08	26	128	6	PF12662
Domain	cEGF	MATN2 FBLN1 FBLN2 SCUBE2 LRP2 FBN3	1.89e-08	26	128	6	IPR026823
Domain	hEGF	SLIT2 CELSR2 SLIT1 FBN3 NOTCH1 NOTCH4	3.07e-08	28	128	6	PF12661
Domain	SID-1_RNA_chan	SIDT1 SIDT2	4.66e-05	2	128	2	PF13965
Domain	SID1_TM_fam	SIDT1 SIDT2	4.66e-05	2	128	2	IPR025958
Domain	Fol_N	SLIT2 FCGBP SLIT1	4.98e-05	11	128	3	IPR003645
Domain	FOLN	SLIT2 FCGBP SLIT1	4.98e-05	11	128	3	SM00274
Domain	GPCR_Rhodpsn_7TM	MRGPRF MRGPRE CCRL2 TAAR5 OR8J1 OR5M8 OR6P1 OPRM1 LHCGR OR52I2 OR6A2 OR4C3 CCR6 OR4B1 CX3CR1	5.55e-05	670	128	15	IPR017452
Domain	7tm_1	MRGPRF MRGPRE CCRL2 TAAR5 OR8J1 OR5M8 OR6P1 OPRM1 LHCGR OR52I2 OR6A2 OR4C3 CCR6 OR4B1 CX3CR1	6.24e-05	677	128	15	PF00001
Domain	G_PROTEIN_RECEP_F1_1	MRGPRF MRGPRE CCRL2 TAAR5 OR8J1 OR5M8 OR6P1 OPRM1 LHCGR OR52I2 OR6A2 OR4C3 CCR6 OR4B1 CX3CR1	7.12e-05	685	128	15	PS00237
Domain	G_PROTEIN_RECEP_F1_2	MRGPRF MRGPRE CCRL2 TAAR5 OR8J1 OR5M8 OR6P1 OPRM1 LHCGR OR52I2 OR6A2 OR4C3 CCR6 OR4B1 CX3CR1	7.85e-05	691	128	15	PS50262
Domain	GPCR_Rhodpsn	MRGPRF MRGPRE CCRL2 TAAR5 OR8J1 OR5M8 OR6P1 OPRM1 LHCGR OR52I2 OR6A2 OR4C3 CCR6 OR4B1 CX3CR1	7.98e-05	692	128	15	IPR000276
Domain	TIL_dom	MUC5B FCGBP LRP2	1.08e-04	14	128	3	IPR002919
Domain	VWF_type-D	MUC5B VWDE FCGBP	1.65e-04	16	128	3	IPR001846
Domain	VWFD	MUC5B VWDE FCGBP	1.65e-04	16	128	3	PS51233
Domain	VWD	MUC5B VWDE FCGBP	1.65e-04	16	128	3	SM00216
Domain	VWD	MUC5B VWDE FCGBP	1.65e-04	16	128	3	PF00094
Domain	CTCK_1	MUC5B SLIT2 SLIT1	2.38e-04	18	128	3	PS01185
Domain	Notch	NOTCH1 NOTCH4	2.77e-04	4	128	2	IPR008297
Domain	NODP	NOTCH1 NOTCH4	2.77e-04	4	128	2	PF07684
Domain	Notch_NODP_dom	NOTCH1 NOTCH4	2.77e-04	4	128	2	IPR011656
Domain	Notch_NOD_dom	NOTCH1 NOTCH4	2.77e-04	4	128	2	IPR010660
Domain	NOD	NOTCH1 NOTCH4	2.77e-04	4	128	2	PF06816
Domain	NOD	NOTCH1 NOTCH4	2.77e-04	4	128	2	SM01338
Domain	NODP	NOTCH1 NOTCH4	2.77e-04	4	128	2	SM01339
Domain	VWC_out	FRAS1 MUC5B FCGBP	2.81e-04	19	128	3	SM00215
Domain	CT	MUC5B SLIT2 SLIT1	4.40e-04	22	128	3	SM00041
Domain	LNR	NOTCH1 NOTCH4	4.60e-04	5	128	2	PS50258
Domain	Cys_knot_C	MUC5B SLIT2 SLIT1	6.48e-04	25	128	3	IPR006207
Domain	CTCK_2	MUC5B SLIT2 SLIT1	6.48e-04	25	128	3	PS01225
Domain	DUF4749	PDLIM5 LDB3	6.87e-04	6	128	2	PF15936
Domain	DUF4749	PDLIM5 LDB3	6.87e-04	6	128	2	IPR031847
Domain	ANATO	FBLN1 FBLN2	9.57e-04	7	128	2	SM00104
Domain	TB	LTBP4 FBN3	9.57e-04	7	128	2	PF00683
Domain	Notch_dom	NOTCH1 NOTCH4	9.57e-04	7	128	2	IPR000800
Domain	ANAPHYLATOXIN_2	FBLN1 FBLN2	9.57e-04	7	128	2	PS01178
Domain	ANAPHYLATOXIN_1	FBLN1 FBLN2	9.57e-04	7	128	2	PS01177
Domain	ANATO	FBLN1 FBLN2	9.57e-04	7	128	2	PF01821
Domain	Notch	NOTCH1 NOTCH4	9.57e-04	7	128	2	PF00066
Domain	NL	NOTCH1 NOTCH4	9.57e-04	7	128	2	SM00004
Domain	Anaphylatoxin/fibulin	FBLN1 FBLN2	9.57e-04	7	128	2	IPR000020
Domain	-	LTBP4 FBN3	1.27e-03	8	128	2	3.90.290.10
Domain	Calx_beta	FRAS1 SLC8A2	1.27e-03	8	128	2	SM00237
Domain	Calx_beta	FRAS1 SLC8A2	1.63e-03	9	128	2	IPR003644
Domain	TB_dom	LTBP4 FBN3	1.63e-03	9	128	2	IPR017878
Domain	TB	LTBP4 FBN3	1.63e-03	9	128	2	PS51364
Domain	Calx-beta	FRAS1 SLC8A2	1.63e-03	9	128	2	PF03160
Domain	VWC	FRAS1 MUC5B FCGBP	2.23e-03	38	128	3	SM00214
Domain	LAM_G_DOMAIN	SLIT2 CELSR2 SLIT1	2.23e-03	38	128	3	PS50025
Domain	MRGPCRFAMILY	MRGPRF MRGPRE	2.46e-03	11	128	2	IPR026234
Domain	Laminin_G_2	SLIT2 CELSR2 SLIT1	2.58e-03	40	128	3	PF02210
Domain	EGF_dom	STAB2 SCUBE2	2.94e-03	12	128	2	IPR024731
Domain	C8	MUC5B FCGBP	2.94e-03	12	128	2	PF08742
Domain	EGF_3	STAB2 SCUBE2	2.94e-03	12	128	2	PF12947
Domain	TIL	MUC5B FCGBP	2.94e-03	12	128	2	PF01826
Domain	VWF_dom	FRAS1 MUC5B FCGBP	2.97e-03	42	128	3	IPR001007
Domain	LamG	SLIT2 CELSR2 SLIT1	3.39e-03	44	128	3	SM00282
Domain	Unchr_dom_Cys-rich	MUC5B FCGBP	3.46e-03	13	128	2	IPR014853
Domain	C8	MUC5B FCGBP	3.46e-03	13	128	2	SM00832
Domain	Ldl_recept_b	LRP2 LRP6	4.02e-03	14	128	2	PF00058
Domain	LDLRB	LRP2 LRP6	4.02e-03	14	128	2	PS51120
Domain	CUB	CDCP2 SCUBE2 CSMD1	4.60e-03	49	128	3	PF00431
Domain	LY	LRP2 LRP6	4.62e-03	15	128	2	SM00135
Domain	LDLR_classB_rpt	LRP2 LRP6	4.62e-03	15	128	2	IPR000033
Domain	LRRNT	LHCGR SLIT2 SLIT1 AMIGO2	4.63e-03	98	128	4	IPR000372
Domain	LRRNT	LHCGR SLIT2 SLIT1 AMIGO2	4.63e-03	98	128	4	SM00013
Domain	CUB	CDCP2 SCUBE2 CSMD1	4.87e-03	50	128	3	SM00042
Domain	Chemokine_rcpt	CCRL2 CCR6	5.25e-03	16	128	2	IPR000355
Domain	-	CDCP2 SCUBE2 CSMD1	5.44e-03	52	128	3	2.60.120.290
Domain	CUB	CDCP2 SCUBE2 CSMD1	5.74e-03	53	128	3	PS01180
Pathway	REACTOME_RAS_PROCESSING	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.60e-25	45	105	17	MM15671
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 PSMB7 USP17L5 USP17L10 USP17L19 USP17L18 RNF123 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.73e-16	191	105	19	MM15289
Pathway	REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 PSMB7 USP17L5 USP17L10 USP17L19 USP17L18 RNF123 USP17L17 USP17L3 USP17L22 USP17L15 USP17L13	2.63e-15	221	105	19	M27578
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 PSMB7 USP17L5 USP17L10 USP17L19 USP17L18 RNF123 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	5.97e-14	262	105	19	MM15286
Pathway	REACTOME_MAPK_FAMILY_SIGNALING_CASCADES	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 PSMB7 USP17L5 USP17L10 USP17L19 USP17L18 NF1 USP17L17 USP17L6P USP17L3 SEPTIN7 USP17L22 USP17L15 USP17L13	1.79e-13	318	105	20	MM15278
Pathway	REACTOME_DEUBIQUITINATION	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 PSMB7 USP17L5 USP17L10 USP17L19 USP17L18 RNF123 USP17L17 USP17L3 USP17L22 USP17L15 USP17L13	6.42e-13	299	105	19	M27574
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 FBXO40 USP17L4 USP17L2 GCNT3 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 PSMB7 OBSL1 USP17L5 USP17L10 MUC5B USP17L19 CHM NUP205 USP17L18 RNF123 USP17L17 USP17L3 USP17L22 UHRF2 USP17L15 ALPL USP17L13	7.17e-06	1475	105	27	M19806
Pathway	REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION	USP17L21 FBXO40 USP17L4 USP17L2 GCNT3 USP17L12 USP17L1 USP17L20 USP17L11 PSMB7 USP17L5 USP17L10 MUC5B USP17L19 CHM NUP205 USP17L18 RNF123 USP17L17 USP17L6P USP17L3 USP17L22 UHRF2 USP17L15 ALPL USP17L13	7.45e-06	1389	105	26	MM15307
Pathway	REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES	FBLN1 FBLN2 LTBP4 FBN3	1.59e-04	37	105	4	M27134
Pathway	WP_PEPTIDE_GPCRS	OPRM1 LHCGR CCR6 ACKR1 CX3CR1	2.38e-04	75	105	5	M39696
Pathway	REACTOME_ELASTIC_FIBRE_FORMATION	FBLN1 FBLN2 LTBP4 FBN3	3.14e-04	44	105	4	M26969
Pathway	REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3	NOTCH1 NOTCH4	5.42e-04	5	105	2	M27411
Pathway	REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI	NOTCH1 NOTCH4	5.42e-04	5	105	2	MM14733
Pubmed	DUB-1, a deubiquitinating enzyme with growth-suppressing activity.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.87e-38	21	134	17	8622927
Pubmed	DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokine-inducible in B-lymphocytes.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.87e-38	21	134	17	14583620
Pubmed	DUB-2A, a new member of the DUB subfamily of hematopoietic deubiquitinating enzymes.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.87e-38	21	134	17	11468161
Pubmed	The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.87e-38	21	134	17	8756639
Pubmed	Lymphocyte-specific murine deubiquitinating enzymes induced by cytokines.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.87e-38	21	134	17	12447969
Pubmed	DUB-1, a fate determinant of dynein heavy chain in B-lymphocytes, is regulated by the ubiquitin-proteasome pathway.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.87e-38	21	134	17	18980247
Pubmed	JAK2 is required for induction of the murine DUB-1 gene.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	8.20e-38	22	134	17	9154835
Pubmed	DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.07e-36	24	134	17	8995226
Pubmed	Interleukin 1 receptor signaling regulates DUBA expression and facilitates Toll-like receptor 9-driven antiinflammatory cytokine production.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	3.33e-36	25	134	17	21115691
Pubmed	Decabromodiphenyl ethane affects embryonic development by interfering with nuclear F-actin in zygotes and leads to cognitive and social disorders in offspring mice.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	9.60e-36	26	134	17	35816173
Pubmed	Cdc25A and Dub3 in a high-stakes balancing act.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.05e-35	33	134	18	20228807
Pubmed	The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.23e-35	34	134	18	20403174
Pubmed	DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.23e-35	34	134	18	14699124
Pubmed	The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.23e-35	34	134	18	15780755
Pubmed	USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.23e-35	34	134	18	19188362
Pubmed	Unstable transmission of the RS447 human megasatellite tandem repetitive sequence that contains the USP17 deubiquitinating enzyme gene.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.23e-35	34	134	18	11941478
Pubmed	Hyaluronan- and RNA-binding deubiquitinating enzymes of USP17 family members associated with cell viability.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.23e-35	34	134	18	17109758
Pubmed	The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.23e-35	34	134	18	20388806
Pubmed	Polyclonal and monoclonal antibodies specific for USP17, a proapoptotic deubiquitinating enzyme.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.23e-35	34	134	18	20715989
Pubmed	Human megasatellite DNA RS447: copy-number polymorphisms and interspecies conservation.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.23e-35	34	134	18	9806828
Pubmed	The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.23e-35	34	134	18	20368735
Pubmed	The RS447 human megasatellite tandem repetitive sequence encodes a novel deubiquitinating enzyme with a functional promoter.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.23e-35	34	134	18	10936051
Pubmed	The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.23e-35	34	134	18	21448158
Pubmed	Cytokine-regulated protein degradation by the ubiquitination system.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	4.58e-35	35	134	18	16611142
Pubmed	Lys-63-specific deubiquitination of SDS3 by USP17 regulates HDAC activity.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	4.58e-35	35	134	18	21239494
Pubmed	The deubiquitinating enzyme USP17 blocks N-Ras membrane trafficking and activation but leaves K-Ras unaffected.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	9.12e-35	36	134	18	20147298
Pubmed	Minor Splicing Factors Zrsr1 and Zrsr2 Are Essential for Early Embryo Development and 2-Cell-Like Conversion.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.58e-34	29	134	17	32527007
Pubmed	Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.77e-34	37	134	18	20228808
Pubmed	DUX is a non-essential synchronizer of zygotic genome activation.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.80e-29	50	134	17	31806660
Pubmed	High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15	6.06e-13	10	134	6	24207026
Pubmed	Cell cycle-dependent expression of Dub3, Nanog and the p160 family of nuclear receptor coactivators (NCoAs) in mouse embryonic stem cells.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15	2.65e-12	12	134	6	24695638
Pubmed	ES cell neural differentiation reveals a substantial number of novel ESTs.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15	8.55e-12	14	134	6	11793228
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 MRGPRF USP17L5 USP17L10 USP17L19 USP17L18 SHROOM4 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.58e-11	674	134	19	37196079
Pubmed	CDK4/6-dependent activation of DUB3 regulates cancer metastasis through SNAIL1.	USP17L4 USP17L2 USP17L1 USP17L6P USP17L3 USP17L15	7.61e-11	19	134	6	28067227
Pubmed	Human and mouse proteases: a comparative genomic approach.	USP17L4 USP17L2 USP17L1 USP17L6P PAN2 USP17L3 USP17L15	2.95e-08	81	134	7	12838346
Pubmed	Embryonic demise caused by targeted disruption of a cysteine protease Dub-2.	USP17L2 USP17L15 USP17L13	2.23e-07	4	134	3	22984479
Pubmed	A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220.	USP17L21 USP17L12 USP17L20 USP17L11 USP17L19 USP17L18 USP17L17	4.21e-07	119	134	7	28625976
Pubmed	Nolz1 expression is required in dopaminergic axon guidance and striatal innervation.	OPRM1 SLIT2 NF1 SLIT1 ALDH1A1	2.35e-06	55	134	5	32561725
Pubmed	Differential patterns of NOTCH1-4 receptor expression are markers of glioma cell differentiation.	NOTCH1 NOTCH4	1.47e-05	2	134	2	24305720
Pubmed	Notch signaling in cancer.	NOTCH1 NOTCH4	1.47e-05	2	134	2	12496471
Pubmed	Fibulin-1 and fibulin-2 expression during organogenesis in the developing mouse embryo.	FBLN1 FBLN2	1.47e-05	2	134	2	8850569
Pubmed	The effect of inflammation on the expression and distribution of the MAS-related gene receptors MrgE and MrgF in the murine ileum.	MRGPRF MRGPRE	1.47e-05	2	134	2	21912971
Pubmed	Inhibition of Notch pathway attenuates the progression of human immunodeficiency virus-associated nephropathy.	NOTCH1 NOTCH4	1.47e-05	2	134	2	23389453
Pubmed	Notch signaling: from the outside in.	NOTCH1 NOTCH4	1.47e-05	2	134	2	11112321
Pubmed	Thymosin beta4 induces angiogenesis through Notch signaling in endothelial cells.	NOTCH1 NOTCH4	1.47e-05	2	134	2	23749167
Pubmed	Notch-1 and notch-4 receptors as prognostic markers in breast cancer.	NOTCH1 NOTCH4	1.47e-05	2	134	2	20444726
Pubmed	A novel family of mammalian transmembrane proteins involved in cholesterol transport.	SIDT1 SIDT2	1.47e-05	2	134	2	28785058
Pubmed	The extracellular matrix proteins fibulin-1 and fibulin-2 in the early human embryo.	FBLN1 FBLN2	1.47e-05	2	134	2	8737292
Pubmed	Hepatitis B virus X protein activates Notch signaling by its effects on Notch1 and Notch4 in human hepatocellular carcinoma.	NOTCH1 NOTCH4	1.47e-05	2	134	2	26530164
Pubmed	Expression of ECM proteins fibulin-1 and -2 in acute and chronic liver disease and in cultured rat liver cells.	FBLN1 FBLN2	1.47e-05	2	134	2	19609566
Pubmed	Introduction to Notch signaling.	NOTCH1 NOTCH4	1.47e-05	2	134	2	25053477
Pubmed	Overexpression of a mammalian ethanolamine-specific kinase accelerates the CDP-ethanolamine pathway.	ETNK2 ETNK1	1.47e-05	2	134	2	11044454
Pubmed	Permissive corridor and diffusible gradients direct medial ganglionic eminence cell migration to the neocortex.	SLIT2 SLIT1	1.47e-05	2	134	2	12515855
Pubmed	Slit proteins: molecular guidance cues for cells ranging from neurons to leukocytes.	SLIT2 SLIT1	1.47e-05	2	134	2	12200164
Pubmed	Clinicopathological significance of aberrant Notch receptors in intrahepatic cholangiocarcinoma.	NOTCH1 NOTCH4	1.47e-05	2	134	2	25031748
Pubmed	Lung cells support osteosarcoma cell migration and survival.	ALDH1A1 ALPL	1.47e-05	2	134	2	28122543
Pubmed	Critical role of endothelial Notch1 signaling in postnatal angiogenesis.	NOTCH1 NOTCH4	1.47e-05	2	134	2	17158336
Pubmed	Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.	NF1 CX3CR1	1.47e-05	2	134	2	21157378
Pubmed	Directional guidance of neuronal migration in the olfactory system by the protein Slit.	SLIT2 SLIT1	1.47e-05	2	134	2	10432110
Pubmed	Notch-1 and Notch-4 biomarker expression in triple-negative breast cancer.	NOTCH1 NOTCH4	1.47e-05	2	134	2	22084425
Pubmed	CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches.	CCR6 CX3CR1	1.47e-05	2	134	2	16713979
Pubmed	Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.	NOTCH1 NOTCH4	1.47e-05	2	134	2	23742774
Pubmed	Steerable-filter based quantification of axonal populations at the developing optic chiasm reveal significant defects in Slit2(-/-) as well as Slit1(-/-)Slit2(-/-) embryos.	SLIT2 SLIT1	1.47e-05	2	134	2	23320558
Pubmed	Slit1 and slit2 proteins control the development of the lateral olfactory tract.	SLIT2 SLIT1	1.47e-05	2	134	2	12097499
Pubmed	Systemic RNA Interference Deficiency-1 (SID-1) Extracellular Domain Selectively Binds Long Double-stranded RNA and Is Required for RNA Transport by SID-1.	SIDT1 SIDT2	1.47e-05	2	134	2	26067272
Pubmed	Different susceptibilities of fibulin-1 and fibulin-2 to cleavage by matrix metalloproteinases and other tissue proteases.	FBLN1 FBLN2	1.47e-05	2	134	2	8841408
Pubmed	Endothelial Jarid2/Jumonji is required for normal cardiac development and proper Notch1 expression.	NRG4 NOTCH1 NOTCH4	1.97e-05	14	134	3	21402699
Pubmed	DNA sequence and analysis of human chromosome 8.	USP17L4 USP17L1 USP17L3 CSMD1	3.59e-05	48	134	4	16421571
Pubmed	FOG-2 attenuates endothelial-to-mesenchymal transformation in the endocardial cushions of the developing heart.	NF1 NOTCH1 SMAD6	3.66e-05	17	134	3	17274974
Pubmed	[Replicative association analysis of genetic markers of cognitive traits with Alzheimer's disease in a Russian population].	CSMD1 NOTCH4	4.41e-05	3	134	2	25845235
Pubmed	Notch receptor expression in human brain arteriovenous malformations.	NOTCH1 NOTCH4	4.41e-05	3	134	2	25846406
Pubmed	Cutting Edge: Codeletion of the Ras GTPase-Activating Proteins (RasGAPs) Neurofibromin 1 and p120 RasGAP in T Cells Results in the Development of T Cell Acute Lymphoblastic Leukemia.	NF1 NOTCH1	4.41e-05	3	134	2	26002977
Pubmed	Cloning and expressions of three mammalian homologues of Drosophila slit suggest possible roles for Slit in the formation and maintenance of the nervous system.	SLIT2 SLIT1	4.41e-05	3	134	2	9813312
Pubmed	Differential expression of Notch genes in human osteoblastic cells.	NOTCH1 NOTCH4	4.41e-05	3	134	2	11836628
Pubmed	Axonal growth regulation of fetal and embryonic stem cell-derived dopaminergic neurons by Netrin-1 and Slits.	SLIT2 SLIT1	4.41e-05	3	134	2	16840550
Pubmed	Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation.	NOTCH1 NOTCH4	4.41e-05	3	134	2	14988227
Pubmed	Glucocorticoids down-regulate the extracellular matrix proteins fibronectin, fibulin-1 and fibulin-2 in bone marrow stroma.	FBLN1 FBLN2	4.41e-05	3	134	2	11737251
Pubmed	Notch signaling: cell fate control and signal integration in development.	NOTCH1 NOTCH4	4.41e-05	3	134	2	10221902
Pubmed	Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.	NOTCH1 NOTCH4	4.41e-05	3	134	2	28871079
Pubmed	Mammalian homologues of the Drosophila slit protein are ligands of the heparan sulfate proteoglycan glypican-1 in brain.	SLIT2 SLIT1	4.41e-05	3	134	2	10364234
Pubmed	Intraislet SLIT-ROBO signaling is required for beta-cell survival and potentiates insulin secretion.	SLIT2 SLIT1	4.41e-05	3	134	2	24065825
Pubmed	Notch1 is pan-endothelial at the onset of flow and regulated by flow.	NOTCH1 NOTCH4	4.41e-05	3	134	2	25830332
Pubmed	Slit-mediated repulsion is a key regulator of motor axon pathfinding in the hindbrain.	SLIT2 SLIT1	4.41e-05	3	134	2	16162649
Pubmed	Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches.	NOTCH1 NOTCH4	4.41e-05	3	134	2	18593923
Pubmed	Characterization of Notch Signalling Pathway Members in Normal Prostate, Prostatic Intraepithelial Neoplasia (PIN) and Prostatic Adenocarcinoma.	NOTCH1 NOTCH4	4.41e-05	3	134	2	26341090
Pubmed	A molecular mechanism for the heparan sulfate dependence of slit-robo signaling.	SLIT2 SLIT1	4.41e-05	3	134	2	17062560
Pubmed	Conserved modularity and potential for alternate splicing in mouse and human Slit genes.	SLIT2 SLIT1	4.41e-05	3	134	2	12141424
Pubmed	Delta-like 4/Notch pathway is differentially regulated in benign and malignant thyroid tissues.	NOTCH1 NOTCH4	4.41e-05	3	134	2	22066479
Pubmed	Unique patterns of Notch1, Notch4 and Jagged1 expression in ovarian vessels during folliculogenesis and corpus luteum formation.	NOTCH1 NOTCH4	4.41e-05	3	134	2	15939383
Pubmed	Endothelial Notch signaling is upregulated in human brain arteriovenous malformations and a mouse model of the disease.	NOTCH1 NOTCH4	4.41e-05	3	134	2	19546852
Pubmed	NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.	NOTCH1 NOTCH4	4.41e-05	3	134	2	21679465
Pubmed	CCR6 promotes steady-state mononuclear phagocyte association with the intestinal epithelium, imprinting and immune surveillance.	CCR6 CX3CR1	4.41e-05	3	134	2	28746740
Pubmed	New neurons follow the flow of cerebrospinal fluid in the adult brain.	SLIT2 SLIT1	4.41e-05	3	134	2	16410488
Pubmed	Disrupted Slit-Robo signalling results in membranous ventricular septum defects and bicuspid aortic valves.	SLIT2 SLIT1 NOTCH1	5.18e-05	19	134	3	25691540
Pubmed	Transcription and Signaling Regulators in Developing Neuronal Subtypes of Mouse and Human Enteric Nervous System.	SEMA4G ZNF250 SLIT2 CELSR2 CSPG5 SLIT1 NOTCH1	5.65e-05	251	134	7	29031500
Pubmed	Evolution of Cortical Neurogenesis in Amniotes Controlled by Robo Signaling Levels.	SLIT2 SLIT1 NOTCH1	6.08e-05	20	134	3	29961574
Pubmed	Erg is a crucial regulator of endocardial-mesenchymal transformation during cardiac valve morphogenesis.	NF1 NOTCH1 NOTCH4	7.07e-05	21	134	3	22932696
Pubmed	Jagged1 is essential for osteoblast development during maxillary ossification.	NOTCH1 NOTCH4 ALPL	8.16e-05	22	134	3	24491691
Pubmed	The 4 Notch receptors play distinct and antagonistic roles in the proliferation and hepatocytic differentiation of liver progenitors.	NOTCH1 NOTCH4	8.80e-05	4	134	2	24145721
Pubmed	A switch in Notch gene expression parallels stem cell to endothelial transition in infantile hemangioma.	NOTCH1 NOTCH4	8.80e-05	4	134	2	20069356
Interaction	NTN5 interactions	FRAS1 VWDE LRP2 LTBP4 NOTCH1	2.90e-07	24	122	5	int:NTN5
Interaction	CXCL5 interactions	VWDE FBLN1 FBLN2 TMEM131 ACKR1	5.43e-07	27	122	5	int:CXCL5
Interaction	SIRPD interactions	FRAS1 VWDE CELSR2 LRP6 TMEM131 NOTCH1	1.38e-05	86	122	6	int:SIRPD
Interaction	KLK3 interactions	EGLN3 FRAS1 VWDE SEMA4G LRP6	3.13e-05	60	122	5	int:KLK3
Interaction	OR4B1 interactions	RNF123 OR4B1	3.63e-05	2	122	2	int:OR4B1
Cytoband	4p16.1	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	1.72e-21	79	134	14	4p16.1
Cytoband	Ensembl 112 genes in cytogenetic band chr4p16	USP17L21 USP17L12 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L22 USP17L15 USP17L13	5.18e-15	222	134	14	chr4p16
Cytoband	Ensembl 112 genes in cytogenetic band chr11p15	MRGPRE TRIM34 MUC5B ZBED5 OR52I2 OR6A2 SCUBE2 CNGA4	2.66e-04	564	134	8	chr11p15
Cytoband	Ensembl 112 genes in cytogenetic band chr8p23	USP17L4 USP17L2 USP17L1 USP17L3 CSMD1	6.45e-04	234	134	5	chr8p23
Cytoband	8p23.1	USP17L4 USP17L2 USP17L1 USP17L3	1.11e-03	154	134	4	8p23.1
GeneFamily	Atypical chemokine receptors	CCRL2 ACKR1	2.87e-04	6	80	2	1090
GeneFamily	Fibulins	FBLN1 FBLN2	5.32e-04	8	80	2	556
GeneFamily	Low density lipoprotein receptors	LRP2 LRP6	1.46e-03	13	80	2	634
Coexpression	MADAN_DPPA4_TARGETS	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	8.83e-23	86	132	17	MM1312
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	1.07e-20	112	132	17	MM1095
Coexpression	GERY_CEBP_TARGETS	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	5.60e-18	160	132	17	MM1155
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP	PRKD2 USP17L21 USP17L4 TMEM150A USP17L2 MARVELD1 USP17L12 USP17L1 USP17L20 USP17L11 APAF1 USP17L5 USP17L10 USP17L19 PDLIM5 USP17L18 LDB3 SIDT2 RNPEP USP17L17 USP17L6P USP17L3 LYNX1 USP17L22 USP17L15 USP17L13	2.03e-16	647	132	26	MM981
Coexpression	GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP	PRKD2 USP17L21 USP17L4 TMEM150A USP17L2 MARVELD1 USP17L12 USP17L1 USP17L20 USP17L11 UGT1A7 APAF1 RDH10 USP17L5 OAS3 TRIM34 USP17L10 USP17L19 PDLIM5 USP17L18 LDB3 SIDT2 CELSR2 RNPEP USP17L17 USP17L6P USP17L3 LYNX1 ALDH1A1 USP17L22 USP17L15 USP17L13	9.25e-15	1226	132	32	MM979
Coexpression	MARSON_BOUND_BY_FOXP3_STIMULATED	USP17L21 USP17L4 USP17L2 GCNT3 USP17L12 USP17L1 USP17L20 HSPBAP1 USP17L11 APAF1 USP17L5 USP17L10 USP17L19 ZBED5 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 CX3CR1 USP17L13	2.00e-08	1072	132	22	MM1031
Coexpression	BRUINS_UVC_RESPONSE_LATE	USP17L21 USP17L4 CHIA USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 MATN2 PSMB7 USP17L5 USP17L10 USP17L19 USP17L18 SLIT2 USP17L17 USP17L6P USP17L3 ETNK1 USP17L22 LTBP4 USP17L15 USP17L13	3.11e-08	1198	132	23	MM1062
Coexpression	NABA_ECM_GLYCOPROTEINS	FRAS1 MATN2 CDCP2 VWDE SLIT2 FBLN1 FBLN2 SLIT1 LTBP4 FBN3	6.15e-08	196	132	10	M3008
Coexpression	NABA_ECM_GLYCOPROTEINS	FRAS1 MATN2 CDCP2 VWDE SLIT2 FBLN1 FBLN2 SLIT1 LTBP4	5.63e-07	191	132	9	MM17059
Coexpression	NABA_CORE_MATRISOME	FRAS1 MATN2 CDCP2 VWDE SLIT2 FBLN1 FBLN2 SLIT1 LTBP4 FBN3	1.39e-06	275	132	10	M5884
Coexpression	NABA_CORE_MATRISOME	FRAS1 MATN2 CDCP2 VWDE SLIT2 FBLN1 FBLN2 SLIT1 LTBP4	9.62e-06	270	132	9	MM17057
Coexpression	NABA_MATRISOME	EGLN3 FRAS1 NRG4 MATN2 CDCP2 MUC5B VWDE SEMA4G SLIT2 FBLN1 FBLN2 SCUBE2 CSPG5 SLIT1 LTBP4 FBN3	6.05e-05	1026	132	16	M5889
Coexpression	GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP	GJD2 GCNT3 SFMBT2 SLIT2 LDB3 SLC15A5 CSMD1	6.92e-05	199	132	7	M8082
Coexpression	GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN	MARVELD1 ADCY6 ZBED5 CELSR2 TMEM131 CCR6 AMIGO2	6.92e-05	199	132	7	M9184
Coexpression	GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP	CCRL2 OAS3 TRIM34 PHLPP1 ETNK1 NOTCH1 CAPN15	7.15e-05	200	132	7	M9051
Coexpression	MOREIRA_RESPONSE_TO_TSA_DN	NOTCH1 CX3CR1 ALPL	9.64e-05	18	132	3	M3506
CoexpressionAtlas	kidney_adult_CortVasc_Tie2_top-relative-expression-ranked_1000	DENND5B EGLN3 MARVELD1 CCRL2 TRIM34 PGAP6 PDLIM5 SHROOM4 BCL6B FBLN2 LRP2 PHLPP1 LYNX1 LTBP4 NOTCH4 ALPL	3.49e-06	846	104	16	gudmap_kidney_adult_CortVasc_Tie2_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#4_top-relative-expression-ranked_200	EGLN3 STAB2 CCRL2 BCL6B CX3CR1 NOTCH4	4.09e-06	86	104	6	gudmap_developingKidney_e15.5_Endothelial cells_200_k4
CoexpressionAtlas	kidney_adult_RenMedVasc_Tie2_k-means-cluster#2_top-relative-expression-ranked_1000	PRKD2 CCRL2 TRIM34 PDLIM5 SHROOM4 BCL6B PHLPP1 NOTCH1 NOTCH4	2.30e-05	312	104	9	gudmap_kidney_adult_RenMedVasc_Tie2_k2_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_200	PRKD2 EGLN3 STAB2 BCL6B NOTCH4	4.32e-05	79	104	5	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_200
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_100	EGLN3 STAB2 BCL6B CX3CR1 NOTCH4	5.81e-05	84	104	5	DevelopingKidney_e15.5_Endothelial cells_emap-29977_100
CoexpressionAtlas	kidney_adult_GlomCapSys_Tie2_top-relative-expression-ranked_1000	DENND5B PRKD2 MARVELD1 CCRL2 TRIM34 ADCY6 PDLIM5 SHROOM4 BCL6B PHLPP1 LYNX1 NOTCH1 NOTCH4 ALPL	7.01e-05	852	104	14	gudmap_kidney_adult_GlomCapSys_Tie2_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_100	EGLN3 STAB2 BCL6B NOTCH4	7.56e-05	46	104	4	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_100
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200	MATN2 CPED1 LHCGR SLIT2 ALDH1A1 LTBP4	8.31e-05	146	104	6	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29965_k-means-cluster#4_top-relative-expression-ranked_500	PRKD2 EGLN3 STAB2 CCRL2 BCL6B CX3CR1 NOTCH4	9.70e-05	217	104	7	gudmap_developingKidney_e15.5_Endothelial cells_500_k4
CoexpressionAtlas	dev gonad_e13.5_F_DevVascOvary_Flk_k-means-cluster#3_top-relative-expression-ranked_1000	PRKD2 STAB2 CCRL2 TRIM34 PDLIM5 SHROOM4 BCL6B RNPEP NOTCH1 CX3CR1 NOTCH4	1.11e-04	570	104	11	gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_k3_1000
CoexpressionAtlas	kidney_adult_CortVasc_Tie2_k-means-cluster#2_top-relative-expression-ranked_1000	EGLN3 CCRL2 TRIM34 PDLIM5 SHROOM4 BCL6B PHLPP1 NOTCH4	1.21e-04	302	104	8	gudmap_kidney_adult_CortVasc_Tie2_k2_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29977_top-relative-expression-ranked_200	PRKD2 EGLN3 STAB2 BCL6B CX3CR1 NOTCH4	1.28e-04	158	104	6	DevelopingKidney_e15.5_Endothelial cells_emap-29977_200
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29965_top-relative-expression-ranked_200	EGLN3 STAB2 CCRL2 BCL6B CX3CR1 NOTCH4	1.33e-04	159	104	6	gudmap_developingKidney_e15.5_Endothelial cells_200
CoexpressionAtlas	dev gonad_e11.5_F_ReproVasc_Flk_top-relative-expression-ranked_1000	DENND5B PRKD2 EGLN3 STAB2 CCRL2 STIL PDLIM5 BCL6B RNPEP NOTCH1 CX3CR1 NOTCH4 AMIGO2	1.78e-04	817	104	13	gudmap_dev gonad_e11.5_F_ReproVasc_Flk_1000
CoexpressionAtlas	dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_500	EGLN3 STAB2 CPED1 PDLIM5 LHCGR BCL6B ALDH1A1 NOTCH1 NOTCH4	2.00e-04	414	104	9	gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_500
CoexpressionAtlas	kidney_adult_GlomCapSys_Tie2_k-means-cluster#3_top-relative-expression-ranked_1000	PRKD2 TRIM34 SHROOM4 BCL6B PHLPP1 NOTCH1 NOTCH4	2.05e-04	245	104	7	gudmap_kidney_adult_GlomCapSys_Tie2_k3_1000
CoexpressionAtlas	dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000	PRKD2 EGLN3 STAB2 APAF1 CCRL2 TRIM34 PDLIM5 SHROOM4 BCL6B RNPEP NOTCH1 CX3CR1 NOTCH4	2.10e-04	831	104	13	gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000
CoexpressionAtlas	dev gonad_e11.5_M_ReproVasc_Flk_k-means-cluster#4_top-relative-expression-ranked_1000	DENND5B PRKD2 STAB2 CCRL2 PDLIM5 BCL6B RNPEP NOTCH1 CX3CR1 NOTCH4	2.16e-04	514	104	10	gudmap_dev gonad_e11.5_M_ReproVasc_Flk_k4_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_500	PSMB7 OBSL1 FBLN2 ETNK2 ALDH1A1	2.46e-04	114	104	5	gudmap_developingGonad_e12.5_epididymis_k3_500
CoexpressionAtlas	dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000	PRKD2 EGLN3 STAB2 APAF1 CCRL2 CPED1 PDLIM5 LHCGR BCL6B ALDH1A1 NOTCH1 CX3CR1 NOTCH4	2.53e-04	847	104	13	gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#2_top-relative-expression-ranked_1000	OBSL1 FBLN2 ETNK2 ALDH1A1 LTBP4 ALPL	2.68e-04	181	104	6	gudmap_developingGonad_e14.5_ testes_1000_k2
CoexpressionAtlas	lung	CHIA SHROOM4 FBN3 NOTCH4 ALPL SMAD6	2.76e-04	182	104	6	lung
CoexpressionAtlas	gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K3	EGLN3 STAB2 BCL6B NEURL3 NOTCH4 AMIGO2	3.02e-04	185	104	6	gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K3
CoexpressionAtlas	B cells, B.Fo.PC, IgD+ IgM+ CD19+ CD43- CD5- CD23+, Peritoneal Cavity, avg-3	DENND5B FGD2 SIDT1 TRIM34 PHLPP1 CCR6 LYNX1 AMIGO2	3.41e-04	352	104	8	GSM538198_500
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	MATN2 RDH10 CPED1 SLIT2 FBLN1 FBLN2 ALDH1A1 CSMD1 LTBP4	3.41e-04	445	104	9	GSM777043_500
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#5_top-relative-expression-ranked_500	PRKD2 EGLN3 STAB2 CCRL2 BCL6B NOTCH4	3.78e-04	193	104	6	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k5_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500	MATN2 OBSL1 CPED1 SLIT2 FBLN2 ETNK2 ALDH1A1 LTBP4	4.26e-04	364	104	8	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500
CoexpressionAtlas	dev gonad_e11.5_M_ReproVasc_Flk_top-relative-expression-ranked_1000	DENND5B PRKD2 EGLN3 STAB2 CCRL2 STIL PDLIM5 BCL6B RNPEP NOTCH1 CX3CR1 NOTCH4	5.14e-04	795	104	12	gudmap_dev gonad_e11.5_M_ReproVasc_Flk_1000
CoexpressionAtlas	kidney_e15.5_SmlBldVes_Tie2_k-means-cluster#4_top-relative-expression-ranked_1000	PRKD2 EGLN3 TRIM34 BCL6B NEURL3 NOTCH1 NOTCH4	5.32e-04	287	104	7	gudmap_kidney_e15.5_SmlBldVes_Tie2_k4_1000
ToppCell	cellseq-Epithelial-Epithelial_Glandular-Goblet\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LINC01559 GCNT3 RDH10 MUC5B SLC5A1 FCGBP ALDH1A1 ADGRF1	8.59e-08	193	127	8	71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35
ToppCell	cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	LINC01559 GCNT3 RDH10 MUC5B SLC5A1 FCGBP ALDH1A1 ADGRF1	8.59e-08	193	127	8	b05e110b13d35d34294357c8e1c4fd23bf4b6c92
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell_prolif\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MATN2 CCRL2 BCL6B FBLN2 LTBP4 NOTCH1 NOTCH4	4.47e-07	163	127	7	1feb4ef7b8abcfca9a72c8d13c40548de79e7db2
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MARVELD1 ADCY6 SHROOM4 FBLN2 LTBP4 NOTCH4 SMAD6	1.01e-06	184	127	7	087666ba949b129c53d7ace40f9e543e3875a7de
ToppCell	droplet-Lung-nan-21m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MARVELD1 ADCY6 SHROOM4 FBLN2 LTBP4 NOTCH4 SMAD6	1.08e-06	186	127	7	5d0cd07b6b51e8ce9e1da949f757dc4575ec5752
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RDH10 MUC5B SLC5A1 FCGBP DNAJC10 ALDH1A1 ALPL	1.16e-06	188	127	7	5901b276f2379abf486b8285957277e95f08464e
ToppCell	Goblet_1\|World / shred by cell class for nasal brushing	LINC01559 GCNT3 RDH10 FCGBP LYNX1 ADGRF1 ALPL	1.49e-06	195	127	7	d9e4889a2e7b7c97c07c15b043b77837739462e4
ToppCell	Secretory\|World / shred by cell class for bronchial biopsy	RDH10 FCGBP DNAJC10 LYNX1 ALDH1A1 ADGRF1 ALPL	1.49e-06	195	127	7	52f8281fe0df67cec3faa780a23ed6343ed5a6ba
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RDH10 MUC5B SLC5A1 FCGBP ALDH1A1 ADGRF1 ALPL	1.54e-06	196	127	7	c18874f37b90e6afacc562b2082b67ea8a7cb4a4
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RDH10 MUC5B SLC5A1 FCGBP DNAJC10 ADGRF1 ALPL	1.54e-06	196	127	7	2c3fbfbb08cd327cd97b3fa5a6f83b6d50771fb7
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GCNT3 RDH10 MUC5B LYNX1 ALDH1A1 ADGRF1 ALPL	1.54e-06	196	127	7	a52879a4c822c5e4be569f01f845a795e00c5f4b
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GCNT3 RDH10 MUC5B LYNX1 ALDH1A1 ADGRF1 ALPL	1.54e-06	196	127	7	7a4d502550e9e37dc42f2ff1be3c896afe365d7f
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GCNT3 RDH10 MUC5B LYNX1 ALDH1A1 ADGRF1 ALPL	1.54e-06	196	127	7	60ea673ed887fe3890c5cf4ff4165384b76d7361
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LINC01559 GCNT3 RDH10 FCGBP LYNX1 ALDH1A1 ADGRF1	1.59e-06	197	127	7	adb4e27d73ae2e6a39d212c0ead3ac0ad62d9131
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MRGPRF CPED1 PDLIM5 SLIT2 LDB3 SEPTIN7 CSMD1	1.76e-06	200	127	7	c06426f877919bdd267ea2fd7e7973c6619832ae
ToppCell	Parenchyma_COVID-19-Epithelial-TX-Club\|Parenchyma_COVID-19 / Sample group, Lineage and Cell type	GCNT3 RDH10 MUC5B SLC5A1 FCGBP ALDH1A1 ADGRF1	1.76e-06	200	127	7	85f946dd3831acf3488c87efba96689cc2667c3a
ToppCell	Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	MATN2 MRGPRF SLIT2 FBLN1 FBLN2 ALDH1A1 LTBP4	1.76e-06	200	127	7	efdf7066b7dd43e35dbc0d2719b75f250cf54af2
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Club-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GCNT3 RDH10 MUC5B SLC5A1 FCGBP ALDH1A1 ADGRF1	1.76e-06	200	127	7	8a44a4f7ea9358f2194a490e79601c98ff7fdcb0
ToppCell	Lung_Parenchyma-Severe-Epithelial-Epithelial-Club\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	GCNT3 RDH10 MUC5B SLC5A1 FCGBP ALDH1A1 ADGRF1	1.76e-06	200	127	7	30d428510c68da96c7c8cfd472f449ebb9631132
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MARVELD1 FBLN2 LTBP4 NOTCH1 NOTCH4 SMAD6	8.24e-06	166	127	6	7a45785a40b7425f97be67bab1c5ceb69b2bd85a
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MARVELD1 FBLN2 LTBP4 NOTCH1 NOTCH4 SMAD6	8.24e-06	166	127	6	bbd382812f8a84a5d99888de2d7cca3a8b5e4695
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EGLN3 NRG4 LHCGR SLIT2 CSPG5 ACKR1	1.01e-05	172	127	6	e15ab284df6dd241d4481f98864b18c39d757b8c
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FGD2 OAS3 SHROOM4 CCR6 SLC16A10	1.06e-05	101	127	5	86acaa2502f61baa714ae988b73e3e73a71e897e
ToppCell	Fetal_29-31_weeks-Epithelial-lung_goblet_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GCNT3 MUC5B VWDE SLC5A1 FCGBP ADGRF1	1.19e-05	177	127	6	a4c001a8e44142babf9f24dfe6f7b73a70b11b16
ToppCell	Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	GCNT3 MUC5B VWDE SLC5A1 FCGBP ADGRF1	1.19e-05	177	127	6	363e07b0f347f3716d530a28ead854b98e27d37c
ToppCell	facs-Brain_Myeloid-Cortex-24m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHIA GCNT3 SLC5A1 FBLN2 LYNX1 LTBP4	1.27e-05	179	127	6	bc93883c2094f2e5bfed79facd4994a23968d875
ToppCell	facs-Brain_Myeloid-Cortex-24m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHIA GCNT3 SLC5A1 FBLN2 LYNX1 LTBP4	1.27e-05	179	127	6	0cef6d2eab2015cac0dd340532b24bfec9707330
ToppCell	facs-Brain_Myeloid-Cortex-24m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHIA GCNT3 SLC5A1 FBLN2 LYNX1 LTBP4	1.27e-05	179	127	6	bb2410b3934fcc53396b96b48e0d9843df159b89
ToppCell	facs-Brain_Myeloid-Cortex-24m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CHIA GCNT3 SLC5A1 FBLN2 LYNX1 LTBP4	1.27e-05	179	127	6	065241799cea30da62cb3b6f2f1970bd1b0f4e2b
ToppCell	Mesenchymal_cells-Stromal_fibro.\|Mesenchymal_cells / Lineage and Cell class	MATN2 RDH10 FBLN2 ALDH1A1 LTBP4 AMIGO2	1.35e-05	181	127	6	f8d914fdc06aaa75a4dc9158daf574ca28fa5432
ToppCell	droplet-Marrow-nan-21m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND5B TMEM150A CPED1 CSPG5 ALPL AMIGO2	1.35e-05	181	127	6	97022416d0f5a5ba9c9bd5e70ce95cf4cb19af89
ToppCell	Club-club-8\|World / Class top	MRGPRE MUC5B LDB3 FCGBP SLC15A5 ALDH1A1	1.39e-05	182	127	6	8111d917e588008d947021460ddf8f1e7ae1337a
ToppCell	3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GCNT3 MUC5B SLC5A1 FCGBP DNAJC10 ALDH1A1	1.39e-05	182	127	6	6d7ba2e1f33aaa499a898ed9587197c0ee625e9a
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MARVELD1 ADCY6 SHROOM4 FBLN2 LTBP4 SMAD6	1.39e-05	182	127	6	c7f2d24697affa530b748ab32b1d40bdc1bdc20a
ToppCell	droplet-Lung-21m-Endothelial-arterial_endothelial\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MARVELD1 ADCY6 SHROOM4 FBLN2 LTBP4 SMAD6	1.39e-05	182	127	6	d95635b74e8cd8bc00bfe40340806b59fb9bee43
ToppCell	droplet-Thymus-nan-18m-Myeloid-Plasma_cells_and_B_cells\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND5B TMEM150A CCRL2 CSPG5 ALPL AMIGO2	1.43e-05	183	127	6	ffb1bbbccb34d1a7e99872611f497450039d5019
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 STAB2 MUC5B LDB3 LRP2 CSMD1	1.48e-05	184	127	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 STAB2 MUC5B LDB3 LRP2 CSMD1	1.48e-05	184	127	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FRAS1 STAB2 MUC5B LDB3 LRP2 CSMD1	1.48e-05	184	127	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Marrow-nan-18m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND5B TMEM150A CPED1 CSPG5 ALPL AMIGO2	1.53e-05	185	127	6	238938a4682b44e88a30b86b13af4feeabe9553d
ToppCell	droplet-Thymus-nan-24m-Myeloid-Plasma_cells_and_B_cells\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND5B TMEM150A OBSL1 CPED1 CSPG5 ALPL	1.53e-05	185	127	6	e583f6601f9ed79b0b23d2f9426a4ba8b969230b
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GCNT3 RDH10 MUC5B SLC5A1 FCGBP SCUBE2	1.57e-05	186	127	6	55fe25f4d0f2bc0fd4802a0a375169f2c41472fc
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	EGLN3 RDH10 MUC5B SLC5A1 FCGBP LYNX1	1.62e-05	187	127	6	71d99a1a95d3692a2891da49d4a243bae6e07fd0
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 OAS3 SFMBT2 PDLIM5 SHROOM4 NOTCH4	1.62e-05	187	127	6	dffa8447c2f3fdacf39a7258c6b4e81a25245041
ToppCell	facs-MAT-Fat-3m\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATN2 CPED1 FBLN1 SIDT2 LRP6 ALDH1A1	1.67e-05	188	127	6	7da9750255efbc5cf9aed7e3105a337fac63b9f0
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DENND5B FBLN2 LTBP4 NOTCH1 NOTCH4 SMAD6	1.72e-05	189	127	6	9da012fdfa9a8d488cab710a463a1d70e89f990c
ToppCell	LPS_only-Endothelial-Endothelial-Artery\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SHROOM4 FBLN2 CSMD1 LTBP4 NOTCH4 SMAD6	1.72e-05	189	127	6	b028466fcd36fdeceec752e55a24286a1cd62ae4
ToppCell	BL-critical-LOC-Epithelial-Secretory\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	GCNT3 RDH10 MUC5B SLC5A1 FBLN1 LYNX1	1.77e-05	190	127	6	f2abe4bc28e934287e2dcd7b9399d5af78c5c8cf
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MATN2 RDH10 SFMBT2 FBLN1 FBLN2 LTBP4	1.77e-05	190	127	6	0fea33f2dc1efa23aaa2da1c318482a52a313ff1
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DENND5B FBLN2 LTBP4 NOTCH1 NOTCH4 SMAD6	1.83e-05	191	127	6	3307dbccadb09c62b0e1c0235ec89bb294d748c3
ToppCell	Influenza_Severe-Non-classical_Monocyte\|Influenza_Severe / Disease group and Cell class	FGD2 SFMBT2 SIDT2 LYNX1 CX3CR1 NOTCH4	1.83e-05	191	127	6	197edf6feb1cfc71d88e532d74f77305a42a3486
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GCNT3 RDH10 MUC5B SLC5A1 FCGBP ADGRF1	1.83e-05	191	127	6	529068029fb461df766135576dd0d8b5980f9bc0
ToppCell	facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATN2 MRGPRF CPED1 FBLN1 FBLN2 LTBP4	1.88e-05	192	127	6	a2c31390da4962bda9a936470b0b68fa1f5d47d1
ToppCell	LPS_only-Endothelial-Endothelial-Vein\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EGLN3 SFMBT2 PDLIM5 SHROOM4 FBLN2 ACKR1	1.88e-05	192	127	6	52acaecd3703166f5ce3b328aff7c82bd142fee4
ToppCell	facs-Lung-nan-3m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MATN2 MRGPRF CPED1 FBLN1 FBLN2 LTBP4	1.88e-05	192	127	6	eeab1cef7c36ae824381952c5b2c982368c379fd
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLIT2 FBLN1 FBLN2 SCUBE2 ALDH1A1 LTBP4	1.88e-05	192	127	6	1b228f0929b505de82a39bf64c837887b0e56701
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MATN2 MRGPRF CPED1 FBLN1 FBLN2 LTBP4	1.88e-05	192	127	6	32acd89617934016cd135d2cc797e8e79ae1b37f
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATN2 MRGPRF SLIT2 FBLN1 FBLN2 LTBP4	1.88e-05	192	127	6	c5f8e766453f87847b740d6988c524b3d0ef3765
ToppCell	mild_COVID-19_(asymptomatic)-Non-classical_Monocyte\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	FGD2 SFMBT2 PDLIM5 SIDT2 LYNX1 CX3CR1	1.94e-05	193	127	6	7839040e703877ef321494ad8926a8604729ceda
ToppCell	Endothelial-A-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	MATN2 BCL6B FBLN2 ACKR1 NOTCH4 SMAD6	1.99e-05	194	127	6	e656ac5539e59e321b46706cb8cc423b2c3358a0
ToppCell	cellseq-Epithelial-Epithelial_Glandular\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	GCNT3 RDH10 MUC5B SLC5A1 FCGBP ADGRF1	1.99e-05	194	127	6	d0fb1ff5cf0738881e114a58f0b27489f781d72b
ToppCell	Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	EGLN3 SHROOM4 OR6A2 ACKR1 NOTCH4 SMAD6	1.99e-05	194	127	6	fc2e0081005c0c496e41197a2d06e4a37708221f
ToppCell	18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high\|Distal / Age, Tissue, Lineage and Cell class	MATN2 RDH10 FBLN1 FBLN2 SEPTIN7 LTBP4	2.05e-05	195	127	6	f86737bff21d81673238813df61a15cfe88d0b15
ToppCell	PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_venous_(4)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	EGLN3 STAB2 CCRL2 BCL6B ALDH1A1 ACKR1	2.05e-05	195	127	6	ca2cf2c10db1ad17aa0a2e30aa7079a7ad751ea6
ToppCell	droplet-Bladder-nan-3m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SIDT1 SEMA4G SCUBE2 CSPG5 NOTCH1 ALPL	2.05e-05	195	127	6	d6e2a5a15bea16de5f7ff09318c67d46ea923203
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MATN2 CPED1 PDLIM5 FBLN1 LDB3 LTBP4	2.05e-05	195	127	6	edd4cd8402af81737b2074f9dce71cc6ab09be7e
ToppCell	3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATN2 MRGPRF SLIT2 FBLN1 FBLN2 LTBP4	2.05e-05	195	127	6	1236dc60288c7dd91868e86e9174a2dacd3b11b3
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(nasal)-Club_(nasal)_L.0.2.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LINC01559 RDH10 OAS3 FCGBP LYNX1 ADGRF1	2.05e-05	195	127	6	3f8ed20ad17afe1545e574e5ca5fe33c3704c7f3
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATN2 MRGPRF SLIT2 FBLN1 FBLN2 LTBP4	2.11e-05	196	127	6	e7bfd4fb400ae0c473131d0fa306c26be08a6d03
ToppCell	Influenza_Severe-Non-classical_Monocyte\|World / Disease group and Cell class	FGD2 SIDT2 RNPEP LYNX1 CX3CR1 NOTCH4	2.11e-05	196	127	6	8ef9810ee99082a9c803c7ecad6ceb5710d16b54
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATN2 MRGPRF SLIT2 FBLN1 FBLN2 LTBP4	2.11e-05	196	127	6	82fad623212d986a7fca3496faf3f8c8f5b83a11
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MATN2 BCL6B FBLN2 LTBP4 NOTCH1 NOTCH4	2.11e-05	196	127	6	a20a56d8997d6db2a10046c8801c619a379de83c
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GCNT3 MUC5B SLC5A1 FCGBP ADGRF1 ALPL	2.11e-05	196	127	6	a4d05d85fbafa869df19bba3881020ea433d81fb
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	GCNT3 MUC5B SLC5A1 FCGBP ADGRF1 ALPL	2.11e-05	196	127	6	91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	GCNT3 MUC5B SLC5A1 FCGBP ADGRF1 ALPL	2.11e-05	196	127	6	e819088a74d29e958371aa851ac9c74ec55367b7
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	GCNT3 MUC5B SLC5A1 FCGBP ADGRF1 ALPL	2.11e-05	196	127	6	e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MATN2 MRGPRF SLIT2 FBLN1 FBLN2 LTBP4	2.11e-05	196	127	6	85e5046f774537684e1443c0fc147d562b7068d0
ToppCell	Bronchial_Biopsy-Epithelial-Club\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	RDH10 MUC5B SLC5A1 FCGBP LYNX1 ALPL	2.11e-05	196	127	6	057d150bdf0cad959fd03ec2d1560a96ba03fae9
ToppCell	mild_COVID-19-Non-classical_Monocyte\|World / disease group, cell group and cell class (v2)	FGD2 SFMBT2 PDLIM5 SIDT2 LYNX1 NOTCH4	2.17e-05	197	127	6	368644260f70895052a1d71171a9d882315354dd
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RDH10 MUC5B SLC5A1 FCGBP ALDH1A1 ALPL	2.17e-05	197	127	6	ff19e4c45715752a04541ad6a0cdf5454c9daaa2
ToppCell	Bronchial_Biopsy-Epithelial-Club\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	RDH10 MUC5B SLC5A1 FCGBP LYNX1 ALPL	2.17e-05	197	127	6	3f5dfa892a1f631b96eeb6f4cfc284aee51d1ce6
ToppCell	Mild_COVID-19-Epithelial-Basal/Club\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	GCNT3 MUC5B SLC5A1 FCGBP ADGRF1 ALPL	2.17e-05	197	127	6	4cc5b778e1e2c6c149160fa147c172977c0fa8eb
ToppCell	11.5-Airway-Mesenchymal-Mesenchyme_SERPINF1-high\|Airway / Age, Tissue, Lineage and Cell class	MATN2 MRGPRF RDH10 FBLN1 FBLN2 LTBP4	2.17e-05	197	127	6	9a053a32ff9c3a85ef9a3382453acd619cc48546
ToppCell	proximal-3-Epithelial-Goblet\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GCNT3 RDH10 MUC5B SLC5A1 LYNX1 ADGRF1	2.24e-05	198	127	6	3477202c4f702d8f75231b13d4b5216f56d981d7
ToppCell	Bronchial_Brush-Epithelial-Club\|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	RDH10 MUC5B SLC5A1 FCGBP LYNX1 ALPL	2.24e-05	198	127	6	61292a2b5aacb6080a679a31b70a211bdec59a3b
ToppCell	proximal-Epithelial-Goblet\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GCNT3 RDH10 MUC5B SLC5A1 LYNX1 ADGRF1	2.24e-05	198	127	6	e7e1c430486a81280abc4a7e7f5bc3713dd20737
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RDH10 MUC5B SLC5A1 FCGBP ALDH1A1 ALPL	2.24e-05	198	127	6	778fee7020c82d11ff3984a8e482a23e5d58165f
ToppCell	Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	FBXO40 MRGPRF SEMA4G ZNF250 LDB3 PXYLP1	2.24e-05	198	127	6	cbb63b255bdc92a557c5db1f08f7766ed9346607
ToppCell	COVID-19_Moderate-Non-classical_Monocyte\|World / disease group, cell group and cell class	FGD2 OAS3 PDLIM5 SIDT2 LYNX1 CX3CR1	2.24e-05	198	127	6	8449934e20bb2a34079fb642cae0d4647b9efe51
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RDH10 MUC5B SLC5A1 FCGBP ALDH1A1 ALPL	2.24e-05	198	127	6	7896f9fb89822e8628fe0b90a489c4760c7b876c
ToppCell	proximal-Epithelial-Goblet-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GCNT3 RDH10 MUC5B SLC5A1 LYNX1 ADGRF1	2.24e-05	198	127	6	da7b40eb00bb5e454e1cfcd1219dc0d84712592a
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GCNT3 RDH10 FCGBP LYNX1 ALDH1A1 ADGRF1	2.30e-05	199	127	6	8bf8d7cd774479f065bbbbcb5a4bd1aa91aa0d85
ToppCell	368C-Fibroblasts-Fibroblast-D-\|368C / Donor, Lineage, Cell class and subclass (all cells)	MATN2 MRGPRF SLIT2 FBLN1 FBLN2 LTBP4	2.30e-05	199	127	6	5a425e7d11c5911ff5855c27a7f058a7ed7abbb0
ToppCell	368C-Fibroblasts-Fibroblast-D\|368C / Donor, Lineage, Cell class and subclass (all cells)	MATN2 MRGPRF SLIT2 FBLN1 FBLN2 LTBP4	2.30e-05	199	127	6	66545eb7f65e450b742628fd431956e13330a0d3
ToppCell	Bronchial_Brush-Epithelial-Club\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	RDH10 MUC5B SLC5A1 FCGBP LYNX1 ALPL	2.30e-05	199	127	6	53b87edccc89a3e8a6c5166472f9ef24fcba416c
ToppCell	proximal-Epithelial-Mucous-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	EGLN3 GCNT3 RDH10 MUC5B SLC5A1 FCGBP	2.30e-05	199	127	6	baac580484124b7c36717b607adcf2cb446e631d
ToppCell	Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MATN2 MRGPRF SLIT2 FBLN1 FBLN2 LTBP4	2.30e-05	199	127	6	e1f1950d6f840485e263b83dc81b98910be3ae7a
ToppCell	proximal-Epithelial-Mucous\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	EGLN3 GCNT3 RDH10 MUC5B SLC5A1 FCGBP	2.30e-05	199	127	6	15ba36fa6ad73d0e959e42f18d7acbc14e310dc9
ToppCell	proximal-3-Epithelial-Mucous\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	EGLN3 GCNT3 RDH10 MUC5B SLC5A1 FCGBP	2.30e-05	199	127	6	3018378860de084662be0cc46fce421db3bb9ec9
ToppCell	distal-2-Epithelial-Mucous\|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	GCNT3 RDH10 MUC5B SLC5A1 FCGBP ADGRF1	2.30e-05	199	127	6	c0275b5011c2bb08e873955afe2e213ec8070d0e
Disease	primary ovarian insufficiency (implicated_via_orthology)	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P USP17L3 USP17L22 USP17L15 USP17L13	2.92e-31	46	130	18	DOID:5426 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP17L21 USP17L4 USP17L2 USP17L12 USP17L1 USP17L20 USP17L11 USP17L24 USP17L5 USP17L10 USP17L19 USP17L18 USP17L17 USP17L6P LRP2 USP17L3 USP17L22 USP17L15 USP17L13	1.68e-29	69	130	19	DOID:1682 (implicated_via_orthology)
Disease	Aortic valve disorder	NOTCH1 SMAD6	5.76e-05	3	130	2	cv:C1260873
Disease	myofibrillar myopathy 4 (implicated_via_orthology)	PDLIM5 LDB3	5.76e-05	3	130	2	DOID:0080095 (implicated_via_orthology)
Disease	Aortic valve disorder	NOTCH1 SMAD6	1.15e-04	4	130	2	C1260873
Disease	asialoglycoprotein receptor 1 measurement	SIDT2 CELSR2	1.15e-04	4	130	2	EFO_0020164
Disease	Aortic Valve Disease 1	NOTCH1 SMAD6	1.15e-04	4	130	2	C3887892
Disease	Bicuspid aortic valve	NOTCH1 SMAD6	1.91e-04	5	130	2	C0149630
Disease	uridine measurement	PRKD2 SLIT2 CSMD1	3.77e-04	32	130	3	EFO_0010546
Disease	microcephaly (implicated_via_orthology)	STIL ETNK2 ETNK1	3.77e-04	32	130	3	DOID:10907 (implicated_via_orthology)
Disease	Aortic valve calcification	NOTCH1 SMAD6	3.99e-04	7	130	2	C0428791
Disease	transient cerebral ischemia (biomarker_via_orthology)	SLIT2 NF1 CCR6 NOTCH1 CX3CR1	6.71e-04	157	130	5	DOID:224 (biomarker_via_orthology)
Disease	hemangiopericytoma (is_marker_for)	NOTCH1 NOTCH4	6.80e-04	9	130	2	DOID:264 (is_marker_for)
Disease	Creutzfeldt-Jakob Disease, Familial	CPED1 ALDH1A1	1.46e-03	13	130	2	C0751254
Disease	Creutzfeldt-Jakob disease	CPED1 ALDH1A1	1.46e-03	13	130	2	C0022336
Disease	New Variant Creutzfeldt-Jakob Disease	CPED1 ALDH1A1	1.46e-03	13	130	2	C0376329
Disease	Metabolic Bone Disorder	LRP2 ALPL	1.69e-03	14	130	2	C0005944
Disease	triacylglycerol 46:2 measurement	GTF3C2 CSMD1	1.69e-03	14	130	2	EFO_0010402
Disease	chronic lymphocytic leukemia	PRKD2 OAS3 OPRM1 PHLPP1	1.93e-03	119	130	4	EFO_0000095
Disease	Osteopenia	LRP2 ALPL	1.95e-03	15	130	2	C0029453
Disease	lysophosphatidylethanolamine 18:0 measurement	MATN2 SIDT2	1.95e-03	15	130	2	EFO_0010367
Disease	triacylglycerol 48:1 measurement	GTF3C2 CSMD1	2.51e-03	17	130	2	EFO_0010404
Disease	sinusitis (is_marker_for)	CHIA MUC5B	2.81e-03	18	130	2	DOID:0050127 (is_marker_for)
Disease	interstitial lung disease	MUC5B CSMD1 NOTCH4	3.26e-03	67	130	3	EFO_0004244
Disease	radiation-induced disorder	NOX3 PDLIM5 SLIT2	3.26e-03	67	130	3	EFO_0009565
Disease	atypical femoral fracture, response to bisphosphonate	CSMD1 SMAD6 SLC16A10	3.40e-03	68	130	3	EFO_0009958, EFO_0009960
Disease	triacylglycerol 46:1 measurement	GTF3C2 CSMD1	3.47e-03	20	130	2	EFO_0010401
Disease	triacylglycerol 48:2 measurement	GTF3C2 CSMD1	4.20e-03	22	130	2	EFO_0010405
Disease	nephrosis (biomarker_via_orthology)	LRP2 CX3CR1	4.20e-03	22	130	2	DOID:2527 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
CCCLSPHLQYIAFGD	APAF1	966	O14727
AQPSANGHSLCCLLY	AGPAT4-IT1	146	Q9H0P7
THCCINPLLYAFLDG	CCRL2	291	O00421
SHYGQALCVSFPQPC	RNPEP	116	Q9H4A4
GCNQACYDRAFPISH	GJD2	61	Q9UKL4
HALPSCDALCGGYIQ	CSMD1	921	Q96PZ7
HNGSCRSVCDLFPSY	CSPG5	366	O95196
CLCKVHLYEQAGPSF	CPED1	616	A4D0V7
CLDPQNCYLHTAGAL	ADGRF1	116	Q5T601
FLCTNVIGICTHYPA	ADCY6	296	O43306
LDGTAPACFHYCRAS	CDCP2	431	Q5VXM1
SFDFNCPCLVHYNAL	CALHM3	36	Q86XJ0
FLHCCLNPVLYAFIG	CCR6	306	P51684
IDPCLCTHLIYAFAG	CHIA	46	Q9BZP6
YGANLEAAAPCHSCN	ACKR1	41	Q16570
ISQQLCVIFTHCYGP	BTBD11	881	A6QL63
GEAHNIFCPAYDCFQ	ANKIB1	371	Q9P2G1
FYHQGQCCIAASRIF	ALDH1A1	296	P00352
VAFSHCCLNPLIYAF	CX3CR1	281	P49238
RGIYLHGNPFVCDCS	AMIGO2	221	Q86SJ2
HGNPFVCDCSLYSLL	AMIGO2	226	Q86SJ2
HYLFATCNCIQGPFI	CELSR2	2591	Q9HCU4
IPYAACPAICVANTH	ANGEL2	296	Q5VTE6
CECPAGFNYNSILLA	FBN3	1746	Q75N90
FRCHCQAGYTPDATA	FBN3	2386	Q75N90
PCLHEVGFCYLDNFL	EGLN3	21	Q9H6Z9
PGLCNYVFSEHCRAA	MUC5B	96	Q9HC84
CAVFGGIYCLRHSVQ	CHM	391	P24386
KIHFISPNIYCCGAG	PSMB7	76	Q99436
PSHKSFCLNGGLCYV	NRG4	11	Q8WWG1
ANGPQCAHYCFSLLK	NUP205	521	Q92621
LEPGEYAVVCCAFNH	CAPN15	886	O75808
CIQAAGPAHAGLYTC	OBSL1	1231	O75147
FAGLEPHIPNAYCNC	PAN2	516	Q504Q3
HFCIALGYTNSCLNP	OPRM1	321	P35372
NGGQCLPFEASYICH	NOTCH1	151	P46531
PSGECLAQCRAHFYL	FRAS1	691	Q86XX4
ATLTYPSHCCAFRNL	LHCGR	271	P22888
SYLCQCHEGFALNPD	MATN2	341	O00339
ICAVCHVNLEGQPFY	LDB3	696	O75112
AHSCAPKLYCTFQNG	ETNK2	136	Q9NVF9
SYHCACFPGFSLQDD	FBLN2	626	P98095
YHKRCAFSIPNNCSG	PRKD2	176	Q9BZL6
GFVCGCPAHYSLNAD	LRP6	911	O75581
HLCLLSSQGPHFYSC	LRP2	1711	P98164
FQASYLVACCLAGQP	AP5B1	466	Q2VPB7
FYHACDQPGEAVLCI	PGAP6	586	Q9HCN3
YALFGTICHGCEFPI	PDLIM5	531	Q96HC4
VYGFIPHCTQATLCA	PARP4	1086	Q9UKK3
HCAAKPVVYFCLGSA	MRGPRE	261	Q86SM8
YAACIGANLGHCAPA	ALPL	486	P05186
GHICSYRCINIPGSF	FBLN1	491	P23142
HFYCDNVPLLALSCS	OR8J1	176	Q8NGP2
LSYCGPNIINHFFCD	OR6P1	166	Q8NGX9
HTPCHLDSYGCNLVF	HSPBAP1	171	Q96EW2
YHCSICGARFNRPAN	BCL6B	356	Q8N143
TYAAACQAAGATVHP	FCGBP	1111	Q9Y6R7
FQGTCEYLLSAPCHG	FCGBP	3291	Q9Y6R7
DFQGTCEYLLSAPCH	FCGBP	4491	Q9Y6R7
PCSGIHQRAICVYGA	GCNT3	381	O95395
PAACRFAHYFVLCGI	DENND5B	16	Q6ZUT9
CPLAYLGCTFVQNHF	FBXO40	511	Q9UH90
AYHAFLAAAVCGGVC	MARVELD1	136	Q9BSK0
PLAQALDCHVCAYNG	LYNX1	16	P0DP58
SFLCVCPAGYQAAPH	LTBP4	651	Q8N2S1
PNRVCLHCYAFLTGN	FGD2	506	Q7Z6J4
VNFYSPGCSHCHDLA	DNAJC10	151	Q8IXB1
FRVLQAHGCAPQLYC	ETNK1	186	Q9HBU6
HPGTFACACNRGYTL	SCUBE2	381	Q9NQ36
PFCTIKLGYHNCQAA	SLC15A5	66	A6NIM6
LSYCGPNIINHFFCD	OR6A2	171	O95222
LAQEAASCYDHPCFL	OAS3	316	Q9Y6K5
LPFCGSNVVVHSYCE	OR52I2	196	Q8NH67
FCGPNVIDHYFCDLQ	OR4B1	166	Q8NGF8
FCGPNVINHFACDLY	OR4C3	166	Q8NH37
AFCDVALHGPFYSAC	RRN3	446	Q9NYV6
EHPAAFCYQVNGSCP	TAAR5	11	O14804
CPVCGISYSFEHLQA	TRIM34	56	Q9BYJ4
GLLSACYHVCPNYTN	SIDT2	561	Q8NBJ9
AAAADGPTVCCNPYH	SMAD6	251	O43541
CLHCALSYQGATAPL	TMEM150A	156	Q86TG1
CLHNYFCVFLGRGAP	MRGPRF	176	Q96AM1
CSGCAVLAVLGHYVP	RETREG2	191	Q8NC44
SVQGALVHDPCIYCS	SHROOM4	891	Q9ULL8
AFCGPNEINHFYCAD	OR5M8	166	Q8NGP6
YFRHQPSALFCSGSC	PXYLP1	231	Q8TE99
LFIGVNDLCHYCENP	PLB1	1206	Q6P1J6
VFHYPVCVCVAAGIG	NOX3	396	Q9HBY0
LANAFYCQCLPGHTG	NOTCH4	1026	Q99466
PHCNLQVFTYTCDVG	RDH10	106	Q8IZV5
LARFINHCCTPNCYA	SETD1A	1641	O15047
RLGSCSHPAFYLLCV	LINC01559	11	Q495D7
ILVCRACFPDLQHGY	CNGA4	51	Q8IV77
FSCPACRHDLGQNYI	UHRF2	766	Q96PU4
AYHCGLCLQRAPASN	USP17L3	251	A6NCW0
LHYPVSCNCGFVAQE	VWDE	471	Q8N2E2
SLFHPSGCPALYCNA	STIL	641	Q15468
CYQAHALVCPAVASE	SCGB1D4	16	Q6XE38
CGTAFSYQPCFQIHE	ZNF441	146	Q8N8Z8
YVCPLCGKAFNHSTV	ZNF250	311	P15622
PYACAHCGRRFAQSS	ZNF771	146	Q7L3S4
AYHCGLCLQRAPASN	USP17L4	251	A6NCW7
YACGTHAFQPLCAAI	SEMA4G	131	Q9NTN9
GAFYICGQSIHQCLP	ERVFRD-1	296	P60508
NRVQCCLYFIAPSGH	SEPTIN7	156	Q16181
ICYAHPISAVFQPCG	RNF123	1256	Q5XPI4
GVLSACYHVCPNYSN	SIDT1	556	Q9NXL6
PECGVLCRSAYFQTH	ZNF592	771	Q92610
LQCGDHCYVGLPFLS	TMEM131	746	Q92545
AYHCGVCLQRAPASK	USP17L18	251	D6R9N7
YCCPQLFINHRCFSG	SFMBT2	526	Q5VUG0
AYHCGVCLQRAPASK	USP17L5	251	A8MUK1
AYHCGVCLQRAPASK	USP17L21	251	D6R901
AYHCGVCLQRAPASK	USP17L13	251	C9JLJ4
SCHFLLFYGVGCDIP	NF1	621	P21359
AFCDVALHGPFYSAC	RRN3P1	71	Q2M238
LPSAGGCHDNASCLY	STAB2	916	Q8WWQ8
AYHCGVCLQRAPASK	USP17L19	251	D6RCP7
LSHLAIGANPLYCDC	SLIT2	851	O94813
VHGTCLPINAFSYSC	SLIT2	1381	O94813
AYHCGLCLQRAPASN	USP17L1	251	Q7RTZ2
ATPGEECAICFYHAA	NEURL3	196	Q96EH8
AYHCGVCLQRAPASK	USP17L12	251	C9JPN9
YFGNRDAPHAQCVLC	ZBED5	121	Q49AG3
AYHCGVCLQRAPASK	USP17L24	251	Q0WX57
CCSLEHLPANLFYSQ	PHLPP1	646	O60346
SCPGNRAHFVYGIAC	GTF3C2	451	Q8WUA4
AYHCGVCLQRAPASK	USP17L6P	251	Q6QN14
NCPTIICGVHYLYFA	SLC5A1	516	P13866
AYHCGVCLQRAPASK	USP17L22	251	D6RA61
CVHGQCVPLDALSYS	SLIT1	1386	O75093
AYHCGVCLQRAPASK	USP17L15	251	C9J2P7
AYHCGVCLQRAPASK	USP17L17	251	D6RBQ6
GIFCHYLEEGAQCPA	UGT1A7	171	Q9HAW7
AYHCGLCLQRAPASK	USP17L2	251	Q6R6M4
AYHCGVCLQRAPASK	USP17L20	251	D6RJB6
AYHCGVCLQRAPASK	USP17L10	251	C9JJH3
AYHCGVCLQRAPASK	USP17L11	251	C9JVI0
FACGCSFAYQPSLVI	SLC16A10	176	Q8TF71
IFFEPSLYHCLENCG	SLC8A2	396	Q9UPR5